Business Context and Reporting Period
CareDx, Inc. (CDNA) filed this Form 8-K on September 19, 2023, to report a significant regulatory development. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding a regulatory event and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The primary material event reported is the conclusion of a United States Securities and Exchange Commission (SEC) investigation. The SEC staff notified the Company that it does not intend to recommend an enforcement action against CareDx, Inc.
Outlook, Risks, and Management Commentary
- SEC Investigation Conclusion: The SEC investigation covered matters similar to those identified in a civil investigative demand by the United States Department of Justice (DOJ), as well as certain of the Company's accounting and public reporting practices.
- Ongoing DOJ Cooperation: While the SEC matter is resolved, the Company continues to cooperate with the DOJ regarding the civil investigative demand.
- Regulatory Status: The notice of no enforcement action was provided under the guidelines of Securities Act Release No. 5310.
Investor Verification Checklist
- Verify the status of the ongoing Department of Justice (DOJ) civil investigative demand.
- Review prior disclosures regarding the specific accounting and public reporting practices under investigation.
- Confirm the Company's compliance with any conditions or settlements related to the DOJ matter.